# Cancer Clinical Trial Eligibility Criteria: Available Therapy in Non-Curative Settings:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-available-therapy-in-non-curative-settings-guidance-for-industry/d21a3c21-c758-4f3f-b215-edfe13aa09a3

> FDA guidance document: Cancer Clinical Trial Eligibility Criteria: Available Therapy in Non-Curative Settings:  Guidance for Industry. Issue date: July 27, 2022. Get complete insights and analysis.

---

## Details

- Title: Cancer Clinical Trial Eligibility Criteria: Available Therapy in Non-Curative Settings:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2022-07-27
- Comment Close Date: 2021-08-24
- Last Changed: 2022-07-27
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-1802">FDA-2020-D-1802</a>

## Related Documents

- [Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-patients-with-organ-dysfunction-or-prior-or-concurrent-malignancies/05aa2403-3ce3-4030-81d9-e59b704fd60c)
- [Cancer Clinical Trial Eligibility Criteria: Brain Metastases](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-brain-metastases/18dfb9e1-7a58-4743-8321-ecddace907a4)
- [Cancer Clinical Trial Eligibility Criteria: Minimum Age Considerations for Inclusion of Pediatric Patients](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-minimum-age-considerations-for-inclusion-of-pediatric-patients/3666fbd1-9a8e-4d1e-bc77-6f3feec9ce81)